Viral vector manufacturing companies produce engineered viruses used to deliver genetic material into cells for gene therapy, cell therapy, vaccines and research. Their capabilities support programmes from early process development through to GMP clinical and commercial production.
This category includes companies working on:
Browse 15 UK viral vector manufacturing companies below.
Global viral vector CDMO for cell and gene therapy
Oxford Biomedica (OXB) is a global contract development and manufacturing organisation specialising in viral vectors for cell and gene therapy. The company provides lentiviral, adeno-associated virus (AAV), and adenoviral vector development and manufacturing services from early-stage process development through to…
Lentiviral vector yield enhancement via HDAC inhibitors and producer lines
Synthistat is a biotechnology company developing technologies to increase lentiviral vector production for cell and gene therapy manufacturing. Its work combines designed histone deacetylase (HDAC) inhibitors with approaches to modify HEK293 producer cells. The company has reported early laboratory results from…
Lentiviral gene therapy developer for tumours and rare diseases
Santo Therapeutics develops in vivo lentiviral gene therapies for cancer and rare genetic disorders. Its proprietary vector platform supports programmes including ST002, an NF2 gene-replacement therapy for NF2-related schwannomatosis. The company announced the start of an investigator-initiated clinical trial of ST002…
AAV gene therapy platform and clinical pipeline for genetic disease
AskBio UK Ltd is the European headquarters of AskBio Inc., a fully integrated AAV gene therapy company and Bayer AG subsidiary. Operating from Roslin Innovation Centre, the Edinburgh site develops the company's synthetic promoter technology, data-driven gene expression control sequences that complement AskBio's Pro10…
Gene therapy and biologics CDMO with cGMP manufacturing in Liverpool
Pharmaron Biologics (UK) Ltd is a contract development and manufacturing organisation specialising in biologics and cell and gene therapy, operating from cGMP biomanufacturing facilities in Speke, Liverpool. The site offers end-to-end services spanning plasmid design, cell line development, viral vector process…
High-capacity viral vector manufacturing platform for gene therapy
Icosphere Biosciences is a biotechnology company developing manufacturing technology for high-capacity gene therapy vectors. Its platform enables scalable, high-yield, contamination-free production of high capacity adenoviral vectors capable of carrying substantially more genetic material than conventional viral…
Sterile GMP fill/finish CMO for biologics and small molecules
Symbiosis Pharmaceutical Services is a contract manufacturing organisation specialising in sterile GMP fill/finish manufacturing of injectable drug products for clinical trials and low-volume commercial supply. Operating from a purpose-built MHRA-licensed and FDA-inspected facility in Stirling, the company handles a…
Lentiviral vector platform improving yield for advanced cell therapies
Lentitek is a biotechnology company developing proprietary lentiviral vector manufacturing technology for cell and gene therapy developers. Its platform uses novel promoter engineering to reduce unwanted payload gene expression in manufacturing cell lines, improving vector yield, quality and potency. The technology…
Herpesvirus-vectored vaccines for livestock and companion animals
The Vaccine Group develops recombinant herpesvirus-vectored vaccines against infectious diseases affecting livestock and companion animals. Its modular platform is designed to generate durable immune responses in young animals, including those carrying maternally derived antibodies. Development programmes include…
Specialist AAV vector manufacturer for gene therapy developers
Trisk Bio is a contract development and manufacturing organisation specialising in the production of adeno-associated virus vectors for gene therapy applications. Its intensified manufacturing processes use suspension bioreactors and chromatography-based purification to deliver high-purity AAV at scalable yields for…
End-to-end viral vector design, production and gene delivery
VectorBuilder is a global provider of gene delivery solutions offering an integrated suite of research products, custom services, and clinical-grade manufacturing. The company's platform spans viral vector design and cloning, packaging of lentiviral, AAV, and adenoviral vectors, plasmid and IVT mRNA manufacture,…
Cell and gene therapy CDMO with integrated consultancy services
eXmoor Pharma is a Bristol-based contract development and manufacturing organisation specialising in cell and gene therapies. Operating from a 65,000 sq ft MHRA-licensed GMP facility, the company provides services spanning process development, viral vector and cell therapy manufacture, fill and finish, and QP release.…
Global cell and gene therapy CDMO
Minaris Advanced Therapies is a company providing contract development, manufacturing and testing services across the cell and gene therapy lifecycle. Its UK operations originate from the former Oxgene business, contributing proprietary AAV and lentiviral manufacturing technologies. In December 2025 the company…
GMP lentiviral and retroviral vector design and manufacture for CGT
ViroCell Biologics is a specialist contract development and manufacturing organisation providing GMP design and manufacture of lentiviral and retroviral vectors for cell and gene therapy clinical trials. The company serves academic and corporate innovators developing CAR-T therapies, rare disease gene therapies, and…
University of Oxford GMP facility for clinical-grade biologics
The Clinical BioManufacturing Facility is the University of Oxford's GMP-licensed manufacturing facility, producing biological investigational medicinal products for early-phase clinical trials. The facility holds an MHRA Manufacturer's Authorisation for Investigational Medicinal Products and manufactures viral vector…